Fluphenazine treatment of DSM-III-R male schizophrenic patients among the Xhosa.
A comparison of fluphenazine decanoate depot injection used alone and fluphenazine decanoate with fluphenazine HCl i.m. was undertaken in South African Xhosa patients with schizophrenia diagnosed according to DSM-III-R. The combined treatment significantly shortened the length of hospital stay to a mean of 30.5 days from a mean of 40.7 days for the single therapy group. The combined treatment group also obtained significantly higher improvement ratings one week after the start of treatment than the single treatment patients.
Landmark
J
J
University of Western Ontario, London.
Merskey
H
H
Cernovsky
Z Z
ZZ
D000293:Adolescent; D000328:Adult; D005006:Ethnicity / Q000523:psychology*; D005476:Fluphenazine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D012931:Social Environment; D013019:South Africa; D014754:Violence
C011825:fluphenazine depot; D005476:Fluphenazine